 NEW YORK--BUSINESS WIRE-- ClassAction--Bragar Eagel Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Eastern District of Texas on behalf of investors that purchased Reata Pharmaceuticals, Inc. NASDAQ: RETA securities between October 15, 2019 and August 7, 2020 the Class Period. Investors have until December 14, 2020 to apply to the Court to be appointed as lead plaintiff in 